# Novartis Ag (NVS)

Source page: https://stoqly.net/companies/nvs

- **Ticker:** NVS (NYSE)
- **Sector:** Health Care / Pharmaceutical Preparations
- **SEC CIK:** 0001114448
- **Latest annual report:** 20-F filed 2026-02-04 (https://www.sec.gov/Archives/edgar/data/1114448/000111444826000004/nvs-20251231.htm)
- **Data updated:** 2026-11-01

## Key figures

- **Last close:** $160.79 on 2026-10-30
- **Market cap:** $314.3B
- **P/E (trailing):** 22.5x
- **EPS, trailing 12 months:** $7.15
- **Free cash flow:** $17.6B
- **Return on invested capital:** 23.8%
- **Return on equity:** 31.0%
- **Net debt:** $17.3B
- **Change in share count:** −3.9%
- **Piotroski F-score:** 6/9
- **Insider buys, last 90 days:** $0.0M
- **Insider sells, last 90 days:** $0.0M

Definitions: https://stoqly.net/about

## Annual results

From SEC EDGAR XBRL filings. Full table: https://stoqly.net/companies/nvs/figures.csv

| US$ millions | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|
| Operating income | 8,268 | 8,702 | 8,403 | 9,086 | 10,152 | 10,056 | 7,946 | 9,769 | 14,544 | 17,644 |
| Net income | 6,712 | 7,703 | 12,611 | 11,732 | 8,072 | 24,021 | 6,955 | 14,850 | 11,941 | 13,984 |
| Diluted EPS (US$) | 2.80 | 3.25 | 5.38 | 5.06 | 3.52 | 10.63 | 3.17 | 7.10 | 5.87 | 7.15 |
| Operating cash flow | 11,475 | 12,621 | 14,272 | 13,625 | 13,650 | 15,071 | 14,236 | 14,458 | 17,619 | 19,144 |
| Free cash flow | 9,613 | 11,296 | 13,018 | 12,246 | 12,375 | 14,005 | 13,320 | 13,398 | 16,253 | 17,596 |
| Cash | 7,007 | 8,860 | 13,271 | 11,112 | 9,658 | 12,407 | 7,517 | 13,393 | 11,459 | 11,435 |
| Debt and leases | 18,075 | 23,583 | 25,660 | 22,355 | 28,531 | 25,523 | 22,485 | 20,627 | 24,722 | 28,729 |

---

Source: SEC EDGAR filings and end-of-day prices, via Stoqly. For information only — not investment advice or a recommendation to buy, sell or hold any security.